SSG
CDLX icon

Summit Securities Group’s Cardlytics CDLX Stock Holding History

Summit Securities Group’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-130
Closed -$71K – 972
2022
Q1 		$71K Buy
+130
New +$78.6K 0.01% 558

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Summit Securities Group's CDLX Position: Q2 2025 in Review

Summit Securities Group sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 10 shares — an estimated $189 sold.

Summit Securities Group first reported a position in CDLX in Q3 2022 and held it in 3 quarters. The position peaked at $199K in Q4 2023. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

  • Summit Securities Group reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
  • Summit Securities Group sold 10 Cardlytics shares in Q2 2025, an estimated $189.
  • Summit Securities Group first reported a position in Cardlytics in Q3 2022 and held it in 3 quarters.
  • Summit Securities Group's Cardlytics position peaked at $199K in Q4 2023.
  • 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on Summit Securities Group's 13F filing for Q2 2025, filed 12 Aug 2025.